Clearpoint Neuro Inc (CLPT) Stock Price, Quote & News

Company Profile

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 287 9109

Website: www.clearpointneuro.com

Address:

120 S. Sierra Avenue, Suite 100, Solana Beach, United States

MikiTrader Apr. 1 at 7:52 PM

$CLPT Why hasn’t this moved yet? At around 6.5 to 7.5, the risk-reward gets insanely good. And they’re just giving it away for free?

0 · Reply

Twister8 Mar. 31 at 11:07 AM

$CLPT

0 · Reply

inflect1on Mar. 31 at 8:36 AM

$CLPT can’t get much sketchier than that

0 · Reply

Twister8 Mar. 23 at 7:02 PM

$CLPT bull thesis=

0 · Reply

LQQKER_INSIDER Mar. 20 at 8:06 PM

$CLPT Not reflected yet, but these will both be paying off 100%. Both expiring worthless to the buyers. This cat eats those who are too greedy, in either direction. 💋

0 · Reply

flapinux Mar. 20 at 4:07 PM

$CLPT

0 · Reply

Twister8 Mar. 19 at 5:17 PM

$CLPT 95% of Clpt partners will not get past a ph1...biotech experiments.

2 · Reply

InvestorNOR Mar. 19 at 5:12 PM

$CLPT he company was very upbeat about 2026. Its a buy here!

0 · Reply

NY2CHI Mar. 19 at 4:11 PM

$CLPT added here.

1 · Reply

Twister8 Mar. 19 at 3:05 PM

$CLPT where is the pumper? getting hammered.

0 · Reply

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

Mar 6, 2026, 8:00 AM EST - 4 weeks ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026

Jan 23, 2026, 11:16 AM EST - 2 months ago

ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software

Jan 22, 2026, 4:30 PM EST - 2 months ago

ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe

Jan 12, 2026, 8:30 AM EST - 3 months ago

ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Nov 20, 2025, 5:00 PM EST - 4 months ago

ClearPoint Neuro Completes Acquisition of IRRAS

Nov 6, 2025, 4:55 PM EST - 5 months ago

ClearPoint Neuro Reports Third Quarter 2025 Results

Nov 6, 2025, 4:50 PM EST - 5 months ago

ClearPoint Neuro Announces Agreement to Acquire IRRAS

Nov 5, 2025, 5:02 PM EST - 5 months ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025

Oct 7, 2025, 4:15 PM EDT - 6 months ago

ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles

Oct 6, 2025, 4:10 PM EDT - 6 months ago

ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide

Oct 1, 2025, 4:05 PM EDT - 6 months ago

ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System

Sep 25, 2025, 4:05 PM EDT - 6 months ago

ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer

Sep 4, 2025, 4:05 PM EDT - 7 months ago

ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners

Aug 12, 2025, 4:05 PM EDT - 8 months ago

ClearPoint Neuro Reports Second Quarter 2025 Results

Aug 4, 2025, 4:05 PM EDT - 8 months ago

ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio

Jul 23, 2025, 4:05 PM EDT - 9 months ago

ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

May 13, 2025, 4:40 PM EDT - 11 months ago

ClearPoint Neuro Reports First Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 11 months ago

ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI

Apr 25, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room

Feb 26, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results

Feb 14, 2025, 8:00 AM EST - 1 year ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025

Feb 12, 2025, 4:15 PM EST - 1 year ago

ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula

Jan 27, 2025, 4:05 PM EST - 1 year ago

ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0

Nov 13, 2024, 6:15 PM EST - 1 year ago

ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain

Nov 7, 2024, 4:05 PM EST - 1 year ago

ClearPoint Neuro Reports Third Quarter 2024 Results

Oct 31, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024

Oct 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024

Aug 26, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro Announces Early Repayment of $10 Million Note

Jul 17, 2024, 4:05 PM EDT - 1 year ago

ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024

Jun 20, 2024, 8:45 AM EDT - 1 year ago

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons

Jun 1, 2024, 9:00 AM EDT - 2 years ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System

Apr 16, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

Mar 19, 2024, 8:07 AM EDT - 2 years ago

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

Mar 12, 2024, 4:05 PM EDT - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

Mar 1, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

Feb 29, 2024, 8:00 AM EST - 2 years ago

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

Feb 28, 2024, 4:45 PM EST - 2 years ago

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

Jan 24, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

Jan 22, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

Jan 8, 2024, 4:05 PM EST - 2 years ago

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

Oct 26, 2023, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023

Jul 25, 2023, 4:05 PM EDT - 2 years ago

ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023

Jun 9, 2023, 8:40 AM EDT - 3 years ago

Top 5 Health Care Stocks That Are Set To Fly In Q2

BLTE COO IRTC STAA

May 24, 2023, 9:25 AM EDT - 3 years ago

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

May 18, 2023, 4:01 PM EDT - 3 years ago

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

MikiTrader Apr. 1 at 7:52 PM

$CLPT Why hasn’t this moved yet? At around 6.5 to 7.5, the risk-reward gets insanely good. And they’re just giving it away for free?

0 · Reply

Twister8 Mar. 31 at 11:07 AM

$CLPT

0 · Reply

inflect1on Mar. 31 at 8:36 AM

$CLPT can’t get much sketchier than that

0 · Reply

Twister8 Mar. 23 at 7:02 PM

$CLPT bull thesis=

0 · Reply

LQQKER_INSIDER Mar. 20 at 8:06 PM

$CLPT Not reflected yet, but these will both be paying off 100%. Both expiring worthless to the buyers. This cat eats those who are too greedy, in either direction. 💋

0 · Reply

flapinux Mar. 20 at 4:07 PM

$CLPT

0 · Reply

Twister8 Mar. 19 at 5:17 PM

$CLPT 95% of Clpt partners will not get past a ph1...biotech experiments.

2 · Reply

InvestorNOR Mar. 19 at 5:12 PM

$CLPT he company was very upbeat about 2026. Its a buy here!

0 · Reply

NY2CHI Mar. 19 at 4:11 PM

$CLPT added here.

1 · Reply

Twister8 Mar. 19 at 3:05 PM

$CLPT where is the pumper? getting hammered.

0 · Reply

Twister8 Mar. 19 at 2:19 PM

$CLPT Joe looking for partner updates

0 · Reply

erevnon Mar. 18 at 6:47 PM

B. Riley Securities maintains ClearPoint Neuro $CLPT at Buy and raises the price target from $18 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Thinkingman91 Mar. 18 at 3:51 PM

$CLPT offering? Run it first

1 · Reply

AStrokeOfLuck Mar. 18 at 3:48 PM

$CLPT

0 · Reply

lancergg Mar. 18 at 3:40 PM

$CLPT Trash ass company

0 · Reply

Twister8 Mar. 18 at 2:31 PM

$CLPT the company is getting buried in debt, they don't have the sales to back it...tic toc

0 · Reply

Twister8 Mar. 18 at 2:30 PM

$CLPT spaghetti anyone?

0 · Reply

Twister8 Mar. 18 at 2:05 PM

$CLPT baggies could have got out on the QURE news at 13-14…instead they chose to buy more at those prices…

0 · Reply

Twister8 Mar. 18 at 1:59 PM

$CLPT

0 · Reply

Twister8 Mar. 18 at 1:50 PM

$CLPT pump and dump the small niche wannabe…

0 · Reply

Twister8 Mar. 18 at 1:43 PM

$CLPT but but but, the shots on goal… spaghetti anyone?

0 · Reply

NY2CHI Mar. 18 at 1:16 PM

$CLPT another partner showing great data on Parkinson outcomes, preparing for phase 3 later this year. https://www.prnewswire.com/news-releases/aspen-neuroscience-announces-positive-12month-data-from-its-aspiro-clinical-trial-in-a-latebreaking-oral-presentation-at-the-adpd-2026-international-conference-on-alzheimers-and-parkinsons-diseases-302716505.html

1 · Reply

Market Cap	278.25M
Revenue (ttm)	36.97M
Net Income (ttm)	-25.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-69.08%
Debt to Equity Ratio	1.75

Volume	791,000
Avg Vol	827,312
Day's Range	N/A - N/A
Shares Out	29.66M
Stochastic %K	36%
Beta	1.18
Analysts	Strong Sell
Price Target	$25.00